Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage
- PMID: 25691810
- PMCID: PMC4325830
- DOI: 10.2147/TCRM.S70652
Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage
Abstract
Background: The irradiation of head and neck cancer (HNC) often causes damage to the salivary glands. The resulting salivary gland hypofunction and xerostomia seriously reduce the patient's quality of life.
Purpose: To analyze the literature of actual management strategies for radiation-induced hypofunction and xerostomia in HNC patients.
Methods: MEDLINE/PubMed and the Cochrane Library databases were electronically evaluated for articles published from January 1, 1970, to June 30, 2013. Two reviewers independently screened and included papers according to the predefined selection criteria.
Results: Sixty-one articles met the inclusion criteria. The systematic review of the literature suggests that the most suitable methods for managing the clinical and pathophysiological consequences of HNC radiotherapy might be the pharmacological approach, for example, through the use of cholinergic agonists when residual secretory capacity is still present, and the use of salivary substitutes. In addition, a modified diet and the patient's motivation to enhance oral hygiene can lead to a significant improvement.
Conclusion: Radiation-induced xerostomia could be considered a multifactorial disease. It could depend on the type of cancer treatment and the cumulative radiation dose to the gland tissue. A preventive approach and the correct treatment of the particular radiotherapeutic patient can help to improve the condition of xerostomia.
Keywords: management strategies; radiation-induced xerostomia; salivary gland hypofunction.
Figures
Similar articles
-
Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.J Clin Oncol. 2021 Sep 1;39(25):2825-2843. doi: 10.1200/JCO.21.01208. Epub 2021 Jul 20. J Clin Oncol. 2021. PMID: 34283635
-
Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53):lgz016. doi: 10.1093/jncimonographs/lgz016. J Natl Cancer Inst Monogr. 2019. PMID: 31425600 Review.
-
Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review.Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 May;117(5):595-607. doi: 10.1016/j.oooo.2014.01.229. Epub 2014 Feb 6. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014. PMID: 24650370 Review.
-
Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.Support Care Cancer. 2003 Apr;11(4):226-31. doi: 10.1007/s00520-002-0409-5. Epub 2002 Oct 22. Support Care Cancer. 2003. PMID: 12673460 Review.
-
Assessment of post-radiotherapy salivary glands.Br J Radiol. 2011 May;84(1001):393-402. doi: 10.1259/bjr/66754762. Br J Radiol. 2011. PMID: 21511748 Free PMC article. Review.
Cited by
-
Efficacy of photobiomodulation therapy combined with mobile health education in patients with head and neck cancer suffering from chronic xerostomia after radiotherapy: protocol for a three-arm, randomised, placebo-controlled, double-blinded study.BMJ Open. 2024 Jan 24;14(1):e078068. doi: 10.1136/bmjopen-2023-078068. BMJ Open. 2024. PMID: 38267245 Free PMC article.
-
Radiation-Induced Salivary Gland Dysfunction: Mechanisms, Therapeutics and Future Directions.J Clin Med. 2020 Dec 18;9(12):4095. doi: 10.3390/jcm9124095. J Clin Med. 2020. PMID: 33353023 Free PMC article. Review.
-
Ensemble learning approach for prediction of early complications after radiotherapy for head and neck cancer using CT and MRI radiomic features.Sci Rep. 2025 Apr 24;15(1):14229. doi: 10.1038/s41598-025-93676-0. Sci Rep. 2025. PMID: 40274870 Free PMC article.
-
Chronic Phenotypes Underlying Radiation-Induced Salivary Gland Dysfunction.J Dent Res. 2024 Jul;103(8):778-786. doi: 10.1177/00220345241252396. Epub 2024 May 29. J Dent Res. 2024. PMID: 38808518 Free PMC article. Review.
-
Impact of low-level laser therapy on the quality of life of patients with xerostomia undergoing head and neck radiotherapy: a systematic review.Support Care Cancer. 2024 Jan 20;32(2):118. doi: 10.1007/s00520-024-08325-5. Support Care Cancer. 2024. PMID: 38244087
References
-
- Bivona PL. Xerostomia. A common problem among the elderly. N Y State Dent J. 1998;64:46–52. - PubMed
-
- Cassolato SF, Turnbull RS. Xerostomia: clinical aspects and treatment. Gerodontology. 2003;20:64–77. - PubMed
-
- Waltimo T, Christen S, Meurman JH, Filippi A. Dental care of patients with leukemia. Schweiz Monatsschr Zahnmed. 2005;115:308–315. - PubMed
-
- Brand HS, Bots CP, Raber-Durlacher E. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation. Br Dent J. 2009;207:E17. - PubMed
-
- Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Can Dent Assoc. 2006;72:841–846. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous